Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 83.95% vs 30.23% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 266.32% vs 29.63% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 330.00% vs 300.00% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -8.00% vs 4.17% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Hainan Shuangcheng Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 83.95% vs 30.23% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 164.17% vs -25.69% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 266.32% vs 29.63% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 157.66% vs -65.06% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 330.00% vs 300.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 256.36% vs -189.47% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -8.00% vs 4.17% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -4.17% vs 4.35% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






